Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
This completed clinical trial from Beth Israel Medical Center evaluated whether extended platelet parameters can distinguish immune thromboc…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Treatment of ITP With Rituximab and / or Accutane [Phase 2]
A Phase 2 clinical trial evaluating rituximab, with or without isotretinoin (Accutane), for immune thrombocytopenia, sponsored by Peking Uni…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP. [Phase 3]
This Phase 3 randomized trial in children with immune thrombocytopenia compared intravenous immunoglobulin (IVIG) alone to IVIG with high-do…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Thrombocytopenia in Gestational Period [Phase 2, Phase 3]
This clinical trial update notes Phase 2 and Phase 3 studies related to thrombocytopenia during pregnancy in the context of immune thrombocy…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: An Investigation of rhTPO With Different Frequencies in the Management of ITP [Phase 3]
Phase 3 trial evaluating different dosing frequencies of recombinant human thrombopoietin (rhTPO) for immune thrombocytopenia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 clinical trial evaluating dexamethasone at different doses for managing immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP) [Phase 3]
This update reports the completion of a Phase 3 trial evaluating recombinant human thrombopoietin in combination with rituximab for immune t…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Caffeic Acid Tablets as a Second-line Therapy for ITP [Phase 3]
This update notes the completion of a Phase 3 trial evaluating caffeic acid tablets as a second-line therapy for immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP [Phase 3]
A Phase 3 trial comparing rhTPO plus dexamethasone versus high-dose dexamethasone for initial treatment of immune thrombocytopenia has compl…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP [Phase 3]
A Phase 3 trial comparing rhTPO plus Rituximab versus low-dose Rituximab alone in immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 trial comparing high-dose dexamethasone to conventional-dose prednisone for initial treatment of primary immune thrombocytopenia has…
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) [Phase 3]
A Phase 3 trial comparing all-trans retinoic acid plus dexamethasone versus high-dose dexamethasone for initial treatment of primary immune …
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Autoantibody Specificity and Response to IVIG in ITP
A completed Shandong University–sponsored trial evaluating autoantibody specificity in immune thrombocytopenia and the response to intraveno…
-
CLINICAL_TRIALS research · 2016-04-20Clinical Trial Update: Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy [Phase 3]
Phase 3 clinical trial update assessing recombinant human thrombopoietin (rhTPO) for managing immune thrombocytopenia in pregnancy; current …
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
This clinical trial update notes that the study examining macrophage function in spleen tissue from patients with immune thrombocytopenia ha…
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) [Phase 3]
A Phase 3 trial evaluating recombinant human thrombopoietin with rituximab versus high-dose dexamethasone for initial treatment of primary i…
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP） [Phase 3]
Phase 3 multicentre trial evaluating two cycles of rituximab vs standard regimen for steroid-resistant/relapsed immune thrombocytopenia was …
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
A clinical trial evaluating recombinant human interleukin-11 in combination with low-dose rituximab for immune thrombocytopenia has been wit…
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment
A clinical trial evaluating immune parameters in immune thrombocytopenia patients treated with eltrombopag has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP） [Phase 3]
A Phase 3 trial evaluating recombinant human thrombopoietin plus cyclosporin A versus cyclosporin A for steroid-resistant/relapsed immune th…
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP) [Phase 4]
A Phase 4 trial evaluating different cycles of high-dose dexamethasone for initial management of immune thrombocytopenia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP [Phase 2]
A Phase 2 trial comparing high-dose dexamethasone plus thalidomide versus dexamethasone alone for newly diagnosed immune thrombocytopenia ha…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura [Phase 3]
A Phase 3 clinical trial in immune thrombocytopenia completed, with results posted in February 2016; sponsor was Instituto Grifols.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Safety, Tolerability and Efficacy of Single Dose Low Cost Minipool Intravenous Immunoglobulins in Moderately Severe Newly Diagnosed ITP [Phase 2]
Phase 2 clinical trial from Ain Shams University assesses safety, tolerability, and efficacy of a single-dose low-cost minipool intravenous …
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training
Completed clinical trial evaluating the proportion of patients with immune thrombocytopenia who correctly self-administer romiplostim after …